Intercure Ltd. vs Regenxbio Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Regenxbio Inc. is the larger company by market value: $513 M against $51 M for Intercure Ltd., 10.0 times as much (market caps of Aug 1, 2026 for Intercure Ltd. and Oct 6, 2026 for Regenxbio Inc.). Intercure Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Regenxbio Inc. had more revenue: $170 M in the year to December 2025 against $65 M for Intercure Ltd. in the year to December 2024.
- Both made a net loss: $18 M for Intercure Ltd. and $194 M for Regenxbio Inc.
- Intercure Ltd. keeps more of each dollar of sales: a net margin of -28.4% against -113.8% for Regenxbio Inc.
- Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against -33.0% for Intercure Ltd.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Intercure Ltd. INCR · #21,156 in the world | Regenxbio Inc. RGNX · #12,415 in the world |
|---|---|---|
| Profile | ||
| Country | 🇮🇱 Israel | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $51 M | $513 M |
| Revenue | $65 M | $170 M |
| Net income | $-18 M▲ best | $-194 M |
| Employees | — | 372 |
| Valuation | ||
| Price to sales | 0.8× | 3.3× |
| Price to book | 0.5× | 5.0× |
| Free cash flow yield | -37.4% | -24.6%▲ best |
| Profitability | ||
| Gross margin | 12.7% | — |
| Operating margin | -28.1%▲ best | -94.6% |
| Net margin | -28.4%▲ best | -113.8% |
| Return on equity | -15.6%▲ best | -107.0% |
| Growth | ||
| Revenue growth | -33.0% | 104.5%▲ best |
| Revenue growth, 3 years a year | -1.7% | 14.8%▲ best |
| Financial strength | ||
| Debt to equity | 0.3× | — |
| Cash | ||
| Free cash flow margin | -29.9%▲ best | -74.1% |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Aug 2026; ratios FY2024 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Intercure Ltd. or Regenxbio Inc.?
Regenxbio Inc. is the larger company by market value: $513 M against $51 M for Intercure Ltd., 10.0 times as much (market caps of Aug 1, 2026 for Intercure Ltd. and Oct 6, 2026 for Regenxbio Inc.). Intercure Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Intercure Ltd. or Regenxbio Inc.?
Regenxbio Inc. had more revenue: $170 M in the year to December 2025 against $65 M for Intercure Ltd. in the year to December 2024. Both made a net loss: $18 M for Intercure Ltd. and $194 M for Regenxbio Inc.
Which is more profitable, Intercure Ltd. or Regenxbio Inc.?
Intercure Ltd. keeps more of each dollar of sales: a net margin of -28.4% against -113.8% for Regenxbio Inc.
Which is growing faster, Intercure Ltd. or Regenxbio Inc.?
Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against -33.0% for Intercure Ltd.